Notably, the knockdown of BRCA1 was observed to be an effective method of inducing an increase of IGF1R levels in SKOV3 and non-BRCA1-mutated ovarian cancer cells (Fig. 3B and C). Here, IGF1R is linked to ovarian cancer.